Moore Justin Xavier, Akinyemiju Tomi, Bartolucci Alfred, Wang Henry E, Waterbor John, Griffin Russell
Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, United States; Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, United States; Division of Public Health Sciences, Department of Surgery, Washington University in Saint Louis School of Medicine, St Louis, MO, United States.
Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, United States; Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, United States; Department of Epidemiology, University of Kentucky, Lexington, KY, United States.
Cancer Epidemiol. 2018 Aug;55:30-38. doi: 10.1016/j.canep.2018.05.001. Epub 2018 May 25.
Hospitalized cancer patients are nearly 10 times more likely to develop sepsis when compared to patients with no cancer history. We compared the risk of sepsis between cancer survivors and no cancer history participants, and examined whether race was an effect modifier.
We performed a prospective analysis of data from the REasons for Geographic and Racial Differences in Stroke (REGARDS) cohort. We categorized participants as "cancer survivors" or "no cancer history" derived from self-reported responses of being diagnosed with any cancer, excluding non-melanoma skin cancer. We defined sepsis as hospitalization for a serious infection with ≥2 systemic inflammatory response syndrome criteria. We performed Cox proportional hazard models to examine the risk of sepsis after cancer (adjusted for sociodemographics, health behaviors, and comorbidities), and stratified by race.
Among 29,693 eligible participants, 2959 (9.97%) were cancer survivors, and 26,734 (90.03%) were no cancer history participants. Among 1393 sepsis events, the risk of sepsis was higher for cancer survivors (adjusted HR: 2.61, 95% CI: 2.29-2.98) when compared to no cancer history participants. Risk of sepsis after cancer survivorship was similar for Black and White participants (p value for race and cancer interaction = 0.63).
In this prospective cohort of community-dwelling adults we observed that cancer survivors had more than a 2.5-fold increased risk of sepsis. Public health efforts should attempt to mitigate sepsis risk by awareness and appropriate treatment (e.g., antibiotic administration) to cancer survivors with suspected infection regardless of the number of years since cancer remission.
与无癌症病史的患者相比,住院癌症患者发生败血症的可能性几乎高10倍。我们比较了癌症幸存者和无癌症病史参与者发生败血症的风险,并研究种族是否为效应修饰因素。
我们对中风地理和种族差异原因(REGARDS)队列的数据进行了前瞻性分析。我们根据自我报告的被诊断患有任何癌症(不包括非黑色素瘤皮肤癌)的情况,将参与者分为“癌症幸存者”或“无癌症病史”。我们将败血症定义为因严重感染住院且符合≥2条全身炎症反应综合征标准。我们进行了Cox比例风险模型分析,以研究癌症后发生败血症的风险(根据社会人口统计学、健康行为和合并症进行调整),并按种族分层。
在29693名符合条件的参与者中,2959名(9.97%)为癌症幸存者,26734名(90.03%)为无癌症病史参与者。在1393例败血症事件中,与无癌症病史参与者相比,癌症幸存者发生败血症的风险更高(调整后风险比:2.61,95%置信区间:2.29 - 2.98)。黑人与白人参与者在癌症存活后发生败血症的风险相似(种族与癌症交互作用的p值 = 0.63)。
在这个社区居住成年人的前瞻性队列中,我们观察到癌症幸存者发生败血症的风险增加了2.5倍以上。公共卫生工作应通过提高认识和对疑似感染的癌症幸存者进行适当治疗(如使用抗生素)来降低败血症风险,无论癌症缓解后经过了多少年。